Evidence map›Paper›PMID 37728089›Full record

Trial reportSubstance abuse2023

Co-use of Opioid Medications and Alcohol Prevention Study (COAPS).

Alina Cernasev, Kenneth Hohmeier, Craig Field, Adam J Gordon, Stacy Elliott, Kristi Carlston, Grace Broussard, Gerald Cochran

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Substance abuse, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alina CernasevUniversity of Tennessee Health Sciences Center, Nashville, TN, USA.
Kenneth HohmeierUniversity of Tennessee Health Sciences Center, Nashville, TN, USA.
Craig FieldDepartment of Psychology, University of Texas, El Paso, TX, USA.
Adam J GordonDivision of Epidemiology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-2453-8871
Stacy ElliottUniversity of Tennessee Health Sciences Center, Nashville, TN, USA.
Kristi CarlstonDivision of Epidemiology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-2297-9702
Grace BroussardDivision of Epidemiology, University of Utah, Salt Lake City, UT, USA.
Gerald CochranDivision of Epidemiology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-0153-0252
University of Utah · USUniversity of Tennessee at Knoxville · USThe University of Texas at El Paso · US

Funding

Co-Use of Opioid Medications and Alcohol Prevention Study (COAPS)R34AA029447 · NIAAA · UNIVERSITY OF UTAH · PI COCHRAN, GERALD T., HOHMEIER, KENNETH CHARLES · 2022 to 2024
$708k
NIAAA NIH HHS R34 AA029447
6 · The paper itself

Abstract

While there is limited research in the field regarding the various dimensions of co-use of alcohol and opioid medication, particularly related to co-use and levels of severity, our research has shown 20% to 30% of community pharmacy patients receiving opioid pain medications are engaged in co-use. Co-use of alcohol and opioid medications is a significant risk factor for opioid-related overdose. Community pharmacy is a valuable yet underutilized resource and setting for addressing the US opioid epidemic, with an untapped potential for identification of and intervention for risks associated with co-use of alcohol and opioids. This commentary describing the "Co-use of Opioid Medications and Alcohol Prevention Study (COAPS)" offers an innovative and promising approach to mitigating serious risks associated with co-use of alcohol (risk and non-risk use) and opioids in community pharmacy. COAPS aim 1involves adapting an existing opioid misuse intervention to target co-use of alcohol and opioid mediations. COAPS aim 2 involves testing the adapted intervention within a small-scale pilot randomized controlled trial (N = 40) to examine feasibility, acceptability and preliminary efficacy of the intervention versus standard care. COAPS aim 3 involves conducting key informant interviews related to future implementation of larger scale studies or service delivery in community pharmacy settings.

Indexed as

AlcoholismOpioid-Related DisordersPrescription Drug MisuseAnalgesics, OpioidEthanolHumansAnalgesics, OpioidEthanolalcohol useopioid useoverdose preventionpharmacy practice

Identifiers

PMID37728089
PMCPMC10926351
OpenAlexW4386878308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.